Quick Answer
Spyre Therapeutics, Inc. reported Shares Outstanding of 78.19 million shares for fiscal year 2025.
Spyre Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 78.19M | +29.8% |
| 2024 | 60.26M | +67.1% |
| 2023 | 36.06M | +1279.4% |
| 2022 | 2.61M | -94.7% |
| 2021 | 49.36M | +2.9% |
| 2020 | 47.96M | +64.9% |
| 2019 | 29.08M | +20.5% |
| 2018 | 24.14M | +44.8% |
| 2017 | 16.67M | +24.1% |
| 2016 | 13.43M | +1673.4% |
| 2015 | 757,336 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 60.47M | +17.7% | +0.2% |
| June 30, 2025 | 60.37M | +18.9% | +0.2% |
| March 31, 2025 | 60.28M | +64.6% | +0.0% |
| December 31, 2024 | 60.26M | +67.1% | +17.2% |
| September 30, 2024 | 51.40M | +1169.4% | +1.2% |
| June 30, 2024 | 50.78M | -37.3% | +38.6% |
| March 31, 2024 | 36.63M | -44.0% | +1.6% |
| December 31, 2023 | 36.06M | +1279.4% | +790.6% |
- Spyre Therapeutics, Inc. showed an increase of +29.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Spyre Therapeutics, Inc.’s shares outstanding has grown by 10224.3% (from 757.3 thousand shares to 78.19 million shares).
- The most recent figure is from Spyre Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: